$AXGN
Axogen, Inc. Stock $axgn

$axgn Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000080592821000044 Filed on March 01, 2021

Income Statement

Concept	2020 Q4	2020	2019 Q4
Revenue	$32.50M	$112.3M	$28.16M
YoY Change	15.39%	5.24%	20.18%
Cost Of Revenue	$6.120M	$21.58M	$5.430M
YoY Change	12.71%	24.39%	32.44%
Gross Profit	$27.03M	$90.72M	$23.28M
YoY Change	16.11%	1.52%	17.62%
Gross Profit Margin	83.19%	80.78%	82.67%
Selling, General & Admin	$26.82M	$96.06M	$25.24M
YoY Change	6.26%	-6.97%	18.05%
% of Gross Profit	99.22%	105.88%	108.41%
Research & Development	$4.930M	$17.85M	$4.910M
YoY Change	0.41%	1.9%	28.87%
% of Gross Profit	18.24%	19.67%	21.09%
Depreciation & Amortization	$560.0K	$1.507M	$330.0K
YoY Change	69.7%	61.52%	50.0%
% of Gross Profit	2.07%	1.66%	1.42%
Operating Expenses	$31.75M	$113.9M	$30.15M
YoY Change	5.31%	-5.69%	19.69%
Operating Profit	-$4.718M	-$23.18M	-$6.869M
YoY Change	-31.31%	-26.19%	27.27%
Interest Expense	-$610.0K	$1.054M	$430.0K
YoY Change	-241.86%	2535.0%	-32.81%
% of Operating Profit
Other Income/Expense, Net	-$20.00K	-$604.0K	-$50.00K
YoY Change	-60.0%	-126.6%	400.0%
Pretax Income	-$6.010M	-$23.80M	-$7.040M
YoY Change	-14.63%	-18.21%	34.61%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$6.010M	-$23.79M	-$7.038M
YoY Change	-14.61%	-18.36%	34.72%
Net Earnings / Revenue	-18.5%	-21.18%	-24.99%
Basic Earnings Per Share		-$0.60
Diluted Earnings Per Share	-$149.3K	-$0.60	-$178.3K
COMMON SHARES
Basic Shares Outstanding	40.13M	39.97M shares	39.47M
Diluted Shares Outstanding		39.97M shares

Balance Sheet

Concept	2020 Q4	2020	2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$104.0M	$104.0M	$96.50M
YoY Change	7.77%	7.77%	-17.24%
Cash & Equivalents	$48.77M	$48.80M	$35.72M
Short-Term Investments	$55.20M	$55.20M	$60.80M
Other Short-Term Assets	$11.10M	$11.10M	$7.700M
YoY Change	44.16%	44.16%	10.0%
Inventory	$12.53M	$12.50M	$13.86M
Prepaid Expenses
Receivables	$17.62M	$17.60M	$16.94M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$145.3M	$145.3M	$135.0M
YoY Change	7.58%	7.63%	-10.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$38.40M	$54.10M	$14.89M
YoY Change	157.93%	198.9%	85.18%
Goodwill
YoY Change
Intangibles	$2.054M		$1.515M
YoY Change	35.58%
Long-Term Investments
YoY Change
Other Assets	$0.00
YoY Change
Total Long-Term Assets	$56.13M	$56.10M	$19.62M
YoY Change	186.06%	186.22%	112.82%
TOTAL ASSETS
Total Short-Term Assets	$145.3M	$145.3M	$135.0M
Total Long-Term Assets	$56.13M	$56.10M	$19.62M
Total Assets	$201.4M	$201.4M	$154.6M
YoY Change	30.22%	30.27%	-3.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.597M	$4.600M	$8.262M
YoY Change	-44.36%	-44.58%	82.91%
Accrued Expenses	$18.20M	$18.20M	$12.60M
YoY Change	44.44%	44.44%	48.24%
Deferred Revenue	$14.00K		$14.00K
YoY Change	0.0%		-22.22%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$1.736M
YoY Change	-100.0%		6100.0%
Total Short-Term Liabilities	$22.83M	$22.80M	$20.88M
YoY Change	9.34%	9.09%	60.07%
LONG-TERM LIABILITIES
Long-Term Debt	$32.03M	$32.00M	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$3.000K	$23.40M	$15.00K
YoY Change	-80.0%	1362.5%	-78.57%
Total Long-Term Liabilities	$32.03M	$55.40M	$15.00K
YoY Change	213433.33%	3362.5%	-85.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.83M	$22.80M	$20.88M
Total Long-Term Liabilities	$32.03M	$55.40M	$15.00K
Total Liabilities	$78.23M	$78.20M	$22.49M
YoY Change	247.85%	247.56%	70.5%
SHAREHOLDERS EQUITY
Retained Earnings	-$203.6M		-$179.9M
YoY Change	13.22%		19.33%
Common Stock	$326.8M		$312.0M
YoY Change	4.74%		4.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$123.1M	$123.1M	$132.2M
YoY Change
Total Liabilities & Shareholders Equity	$201.4M	$201.4M	$154.6M
YoY Change	30.22%	30.27%	-3.45%

Cashflow Statement

Concept	2020 Q4	2020	2019 Q4
OPERATING ACTIVITIES
Net Income	-$6.010M	-$23.79M	-$7.038M
YoY Change	-14.61%	-18.36%	34.72%
Depreciation, Depletion And Amortization	$560.0K	$1.507M	$330.0K
YoY Change	69.7%	61.52%	50.0%
Cash From Operating Activities	$2.830M	-$9.626M	-$3.330M
YoY Change	-184.98%	-51.56%	-33.0%
INVESTING ACTIVITIES
Capital Expenditures	-$3.300M	$21.91M	-$1.160M
YoY Change	184.48%	369.66%	404.35%
Acquisitions
YoY Change
Other Investing Activities	-$16.06M	$5.630M	$14.74M
YoY Change	-208.96%	-82.68%	67.88%
Cash From Investing Activities	-$19.35M	-$16.96M	$13.58M
YoY Change	-242.49%	-162.2%	58.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$3.500M
YoY Change
Debt Paid & Issued, Net		$0.00
YoY Change
Cash From Financing Activities	4.510M	$40.47M	910.0K
YoY Change	395.6%	904.07%	-16.51%
NET CHANGE
Cash From Operating Activities	2.830M	-$9.626M	-3.330M
Cash From Investing Activities	-19.35M	-$16.96M	13.58M
Cash From Financing Activities	4.510M	$40.47M	910.0K
Net Change In Cash	-12.01M	$13.89M	11.16M
YoY Change	-207.62%	21.48%	138.97%
FREE CASH FLOW
Cash From Operating Activities	$2.830M	-$9.626M	-$3.330M
Capital Expenditures	-$3.300M	$21.91M	-$1.160M
Free Cash Flow	$6.130M	-$31.53M	-$2.170M
YoY Change	-382.49%	28.51%	-54.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0000805928
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:LiabilitiesCurrentAbstract
CY2019Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:LiabilitiesCurrentAbstract
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:LiabilitiesNoncurrentAbstract
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:LiabilitiesNoncurrentAbstract
CY2020Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:LiabilitiesCurrentAbstract
CY2019Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:LiabilitiesCurrentAbstract
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:LiabilitiesNoncurrentAbstract
CY2019Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:LiabilitiesNoncurrentAbstract
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity File Number EntityFileNumber	001-36046
CY2020	dei	Entity Registrant Name EntityRegistrantName	AXOGEN, INC.
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	13631 Progress Blvd., Suite 400
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	Alachua
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-1301878
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32615
CY2020	dei	City Area Code CityAreaCode	386
CY2020	dei	Local Phone Number LocalPhoneNumber	462-6800
CY2020	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2020	dei	Trading Symbol TradingSymbol	AXGN
CY2020	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	dei	Entity Public Float EntityPublicFloat	216633232	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40736714	shares
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1706000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	145251000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17618000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16944000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48767000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35724000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	6842000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	6000000	USD
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	55199000	USD
CY2019Q4	us-gaap	Short Term Investments ShortTermInvestments	60786000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	416000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1092000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	12529000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	13861000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4296000	USD
CY2020Q4	axgn	Lease Liability Current LeaseLiabilityCurrent	863000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	135021000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	38398000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14887000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15614000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3133000	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	64000	USD
CY2019Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	87000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2054000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1515000	USD
CY2020Q4	us-gaap	Assets Assets	201381000	USD
CY2019Q4	us-gaap	Assets Assets	154643000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	21968000	USD
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	19144000	USD
CY2019Q4	axgn	Lease Liability Current LeaseLiabilityCurrent	1736000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	22831000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20880000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	32027000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2020Q4	axgn	Lease Liabilities Noncurrent LeaseLiabilitiesNoncurrent	20874000	USD
CY2019Q4	axgn	Lease Liabilities Noncurrent LeaseLiabilitiesNoncurrent	1595000	USD
CY2020Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	2497000	USD
CY2019Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	0	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	78232000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	22490000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40618766	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40618766	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39589755	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39589755	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	406000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	396000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	326390000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	311618000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-203647000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-179861000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	123149000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	132153000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	201381000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	154643000	USD
CY2020	us-gaap	Revenues Revenues	112300000	USD
CY2019	us-gaap	Revenues Revenues	106712000	USD
CY2018	us-gaap	Revenues Revenues	83937000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	21581000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	17349000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12923000	USD
CY2020	us-gaap	Gross Profit GrossProfit	90719000	USD
CY2019	us-gaap	Gross Profit GrossProfit	89363000	USD
CY2018	us-gaap	Gross Profit GrossProfit	71014000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	69659000	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	71950000	USD
CY2018	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	56617000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17846000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17514000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11773000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	26396000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31305000	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23124000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	113901000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	120769000	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	91514000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-23182000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-31406000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-20500000	USD
CY2020	us-gaap	Investment Income Net InvestmentIncomeNet	605000	USD
CY2019	us-gaap	Investment Income Net InvestmentIncomeNet	2364000	USD
CY2018	us-gaap	Investment Income Net InvestmentIncomeNet	1525000	USD
CY2020	us-gaap	Interest Expense InterestExpense	1054000	USD
CY2019	us-gaap	Interest Expense InterestExpense	40000	USD
CY2018	us-gaap	Interest Expense InterestExpense	1208000	USD
CY2020	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-117000	USD
CY2019	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	USD
CY2018	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-22397000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2186000	USD
CY2020	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	38000	USD
CY2019	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	53000	USD
CY2018	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	28000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-604000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2271000	USD
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1897000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23786000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-29135000	USD
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39967000	shares
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39235000	shares
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	37127000	shares
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.60
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.74
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.60
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	25182000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7606000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3884000	USD
CY2018	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	132707000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-22397000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	146982000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10304000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4002000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-29135000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	132153000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8470000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8470000	USD
CY2020	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	0	USD
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	670000	USD
CY2020	axgn	Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan	3300000	USD
CY2020	axgn	Stock Issued During Period Settlement Of Warrants And Rights Value StockIssuedDuringPeriodSettlementOfWarrantsAndRightsValue	3682000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23786000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	123149000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23786000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-29135000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-22397000	USD
CY2020	us-gaap	Depreciation Depreciation	1507000	USD
CY2019	us-gaap	Depreciation Depreciation	933000	USD
CY2018	us-gaap	Depreciation Depreciation	774000	USD
CY2020	axgn	Right Of Use Asset Amortization RightOfUseAssetAmortization	1800000	USD
CY2019	axgn	Right Of Use Asset Amortization RightOfUseAssetAmortization	1821000	USD
CY2018	axgn	Right Of Use Asset Amortization RightOfUseAssetAmortization	0	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	153000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	123000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	77000	USD
CY2020	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2019	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	104000	USD
CY2019	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	972000	USD
CY2018	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	232000	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2018	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	81000	USD
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3000	USD
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2018	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2186000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-105000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	514000	USD
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	852000	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	2242000	USD
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	1887000	USD
CY2018	us-gaap	Inventory Write Down InventoryWriteDown	1343000	USD
CY2020	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	47000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3767000	USD
CY2018	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	721000	USD
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-117000	USD
CY2019	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
CY2018	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	8470000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	10304000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	7606000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	635000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2136000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5108000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	910000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6009000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2524000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	661000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	192000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4958000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2920000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3711000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	1086000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	1773000	USD
CY2018	us-gaap	Operating Lease Payments OperatingLeasePayments	0	USD
CY2020	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	3000	USD
CY2019	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	4000	USD
CY2018	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	0	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-12000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-30000	USD
CY2018	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-66000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9626000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19872000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17862000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21905000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4664000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6282000	USD
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	77806000	USD
CY2019	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	121074000	USD
CY2018	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	114736000	USD
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	83440000	USD
CY2019	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	153571000	USD
CY2018	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	23146000	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	692000	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	562000	USD
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	321000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16963000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	27271000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-98193000	USD
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	35000000	USD
CY2019	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2018	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	7820000	USD
CY2018	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	7820000	USD
CY2019	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2018	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3500000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	132964000	USD
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	642000	USD
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2018	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	257000	USD
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2019	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2018	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	26253000	USD
CY2020	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2019	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2018	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	30489000	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2018	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	22513000	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	14000	USD
CY2019	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	-29000	USD
CY2018	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3300000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4002000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3884000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	670000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	40474000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4031000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	109842000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	13885000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11430000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6213000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41724000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30294000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36507000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	55609000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41724000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30294000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	822000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	34000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	1325000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1077000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3212000	USD
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	335000	USD
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	5250000	USD
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
CY2018	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
CY2020	axgn	Embedded Derivative Associated With The Long Term Debt EmbeddedDerivativeAssociatedWithTheLongTermDebt	2563000	USD
CY2019	axgn	Embedded Derivative Associated With The Long Term Debt EmbeddedDerivativeAssociatedWithTheLongTermDebt	0	USD
CY2018	axgn	Embedded Derivative Associated With The Long Term Debt EmbeddedDerivativeAssociatedWithTheLongTermDebt	0	USD
CY2020	axgn	Noncash Right Of Use Assets And Operating Lease Liability NoncashRightOfUseAssetsAndOperatingLeaseLiability	14259000	USD
CY2019	axgn	Noncash Right Of Use Assets And Operating Lease Liability NoncashRightOfUseAssetsAndOperatingLeaseLiability	26000	USD
CY2018	axgn	Noncash Right Of Use Assets And Operating Lease Liability NoncashRightOfUseAssetsAndOperatingLeaseLiability	0	USD
CY2020	axgn	Noncash Or Part Noncash Conversion Option NoncashOrPartNoncashConversionOption	182000	USD
CY2019	axgn	Noncash Or Part Noncash Conversion Option NoncashOrPartNoncashConversionOption	0	USD
CY2018	axgn	Noncash Or Part Noncash Conversion Option NoncashOrPartNoncashConversionOption	0	USD
CY2020	us-gaap	Basis Of Accounting BasisOfAccounting	Basis of PresentationThe accompanying consolidated financial statements include the accounts of Axogen, Inc. (the “Company” or “Axogen”) and its wholly owned subsidiaries, Axogen Corporation (“AC”), Axogen Processing Corporation (“APC”) and Axogen Europe GmbH, as of December 31, 2020 and December 31, 2019 and for the three years ended December 31, 2020. The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. All intercompany accounts and transactions have been eliminated in consolidation.
CY2020	us-gaap	Nature Of Operations NatureOfOperations	Organization and Business<div style="margin-top:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Axogen is the leading company focused specifically on the science, development, and commercialization of the technologies for peripheral nerve regeneration and repair. Axogen is passionate about providing the opportunity to restore nerve function and quality of life for patients with peripheral nerve injuries. Axogen providing innovative, clinically proven and economically effective repair solutions for surgeons and health care providers. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve or the inability to properly reconnect peripheral nerves can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain.</span></div><div style="margin-top:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Axogen’s platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; Axoguard Nerve Connector, a porcine submucosa extracellular matrix (“ECM”) coaptation aid for tensionless repair of severed peripheral nerves; Axoguard Nerve Protector, a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments; Axoguard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nerve Cap, a porcine submucosa ECM product used to protect a peripheral nerve end and separate the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord intended for surgical use as a resorbable soft tissue conduit. Along with these core surgical products, Axogen also offers the Axotouch Two-Point Discriminator, used to measure the innervation density of any surface area of skin. The Company’s portfolio of products is available in the United States, Canada, Germany, United Kingdom, Spain, South Korea, and several other countries.</span></div><div style="margin-top:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Avance Nerve Graft and Avive Soft Tissue Membrane are processed in the United States by Axogen at its processing facility in Dayton, Ohio. Axoguard Nerve Cap is manufactured by Cook Biotech in the United States for sale by Axogen and Axoguard Nerve Connector and Axoguard Nerve Protector are manufactured in the United States by Cook Biotech and are distributed worldwide exclusively by Axogen. The Axotouch Two Point Discriminator is contract manufactured by Viron Technologies, LLC (doing business as Cybernetics Research Laboratories) (“CLR”) Tucson, Arizona. CRL supplies the Axotouch unpackaged and they are packaged at Axogen’s distribution facility in Burleson, Texas. Axogen maintains its corporate offices in Alachua, Florida and is the parent company of its wholly owned operating subsidiaries, AC, APC and Axogen Europe GmbH.</span></div>
CY2020Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	48267000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	6842000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	6000000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	14000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41724000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48767000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35724000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	6842000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	6000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	55609000	USD
CY2019Q4	us-gaap	Accounts Receivable Billed For Long Term Contracts Or Programs AccountsReceivableBilledForLongTermContractsOrPrograms	16944000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	15000	USD
	axgn	Increase Decrease In Contract Receivable IncreaseDecreaseInContractReceivable	1623000	USD
CY2018Q4	us-gaap	Accounts Receivable Billed For Long Term Contracts Or Programs AccountsReceivableBilledForLongTermContractsOrPrograms	15321000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	18000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	42000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1092000	USD
	axgn	Increase Decrease In Contract With Customer Liability Current IncreaseDecreaseInContractWithCustomerLiabilityCurrent	-4000	USD
	axgn	Increase Decrease In Contract With Customer Liability Noncurrent IncreaseDecreaseInContractWithCustomerLiabilityNoncurrent	-27000	USD
CY2019Q4	us-gaap	Accounts Receivable Billed For Long Term Contracts Or Programs AccountsReceivableBilledForLongTermContractsOrPrograms	16944000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	14000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	15000	USD
CY2020Q4	us-gaap	Accounts Receivable Billed For Long Term Contracts Or Programs AccountsReceivableBilledForLongTermContractsOrPrograms	17618000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	14000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	3000	USD
	axgn	Increase Decrease In Contract Receivable IncreaseDecreaseInContractReceivable	674000	USD
	axgn	Increase Decrease In Contract With Customer Liability Current IncreaseDecreaseInContractWithCustomerLiabilityCurrent	0	USD
	axgn	Increase Decrease In Contract With Customer Liability Noncurrent IncreaseDecreaseInContractWithCustomerLiabilityNoncurrent	-12000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	416000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17846000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17514000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11773000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	8470000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	10304000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	7606000	USD
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Use of Estimates</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"/></div><div style="margin-top:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Management believes the critical accounting policies regarding revenue recognition, inventory and share-based employee compensation affect the Company's more significant judgments and estimates used in the preparation of the Company’s consolidated financial statements. Actual results could differ materially from those estimates.</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"/></div>
CY2020	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Reclassifications</span></div><div style="margin-top:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"Contract liabilities, current" of $14 were reported in the Company's consolidated balance sheets as of December 31, 2019 have been combined into "Accounts payable and accrued expenses" in the Company's consolidated balance sheets to conform with the presentation as of December 31, 2020.</span></div>
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8876000	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	10403000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	751000	USD
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	730000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2902000	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2728000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	12529000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	13861000	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	2242000	USD
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	1887000	USD
CY2018	us-gaap	Inventory Write Down InventoryWriteDown	1343000	USD
CY2019Q4	axgn	Prepaid Events Current PrepaidEventsCurrent	110000	USD
CY2020Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	587000	USD
CY2020Q4	us-gaap	Prepaid Insurance PrepaidInsurance	2596000	USD
CY2019Q4	us-gaap	Prepaid Insurance PrepaidInsurance	0	USD
CY2020Q4	axgn	Stock Option Receivable Current StockOptionReceivableCurrent	2000	USD
CY2019Q4	axgn	Stock Option Receivable Current StockOptionReceivableCurrent	244000	USD
CY2020Q4	us-gaap	Insurance Receivable For Malpractice Current InsuranceReceivableForMalpracticeCurrent	23000	USD
CY2019Q4	us-gaap	Insurance Receivable For Malpractice Current InsuranceReceivableForMalpracticeCurrent	98000	USD
CY2020Q4	axgn	Prepaid Events Current PrepaidEventsCurrent	203000	USD
CY2019Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	227000	USD
CY2020Q4	axgn	Prepaid Software License Current PrepaidSoftwareLicenseCurrent	220000	USD
CY2019Q4	axgn	Prepaid Software License Current PrepaidSoftwareLicenseCurrent	207000	USD
CY2020Q4	axgn	Prepaid Professional Fees Current PrepaidProfessionalFeesCurrent	251000	USD
CY2019Q4	axgn	Prepaid Professional Fees Current PrepaidProfessionalFeesCurrent	433000	USD
CY2020Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	414000	USD
CY2019Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	387000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4296000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1706000	USD
CY2020Q4	us-gaap	Prepaid Insurance PrepaidInsurance	2596000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	43223000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18651000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4825000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3764000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	38398000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14887000	USD
CY2020	us-gaap	Depreciation Depreciation	1507000	USD
CY2019	us-gaap	Depreciation Depreciation	933000	USD
CY2018	us-gaap	Depreciation Depreciation	774000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2589000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	884000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	2973000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1515000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1705000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1912000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	731000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1181000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2938000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	884000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2054000	USD
CY2019Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2246000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	731000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	153000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	123000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	77000	USD
CY2019Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	104000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4597000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8262000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3778000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3251000	USD
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	13593000	USD
CY2019Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	7631000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	21968000	USD
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	19144000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	35000000	USD
CY2019Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	0	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	8470000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10304000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4002000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3884000	USD
CY2019Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	0	USD
CY2018Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	117000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	32027000	USD
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	0	USD
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020	axgn	Share Base Payment Arrangement Number Of Plans ShareBasePaymentArrangementNumberOfPlans	2	plan
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7606000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3300000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	USD
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y10M17D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y9M3D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y2M19D
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5846
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5497
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5099
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0049
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0171
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0270
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	3811000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	1467000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	196000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	42317000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	36250000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	30588000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	397000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	317000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	273000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	136000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1145000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	USD
CY2020Q4	axgn	Deferred Tax Assets Interest Limitation DeferredTaxAssetsInterestLimitation	115000	USD
CY2019Q4	axgn	Deferred Tax Assets Interest Limitation DeferredTaxAssetsInterestLimitation	0	USD
CY2018Q4	axgn	Deferred Tax Assets Interest Limitation DeferredTaxAssetsInterestLimitation	336000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	106000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	274000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	285000	USD
CY2020Q4	axgn	Deferred Tax Assets Right Of Use Liability DeferredTaxAssetsRightOfUseLiability	5551000	USD
CY2019Q4	axgn	Deferred Tax Assets Right Of Use Liability DeferredTaxAssetsRightOfUseLiability	837000	USD
CY2018Q4	axgn	Deferred Tax Assets Right Of Use Liability DeferredTaxAssetsRightOfUseLiability	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3218000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3140000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2335000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	51704000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	40954000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	33934000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	34000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	206000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	43000	USD
CY2020Q4	axgn	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	4004000	USD
CY2019Q4	axgn	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	809000	USD
CY2018Q4	axgn	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	4000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	7000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	15000	USD
CY2020Q4	axgn	Deferred Tax Assets Liabilities DeferredTaxAssetsLiabilities	46517000	USD
CY2019Q4	axgn	Deferred Tax Assets Liabilities DeferredTaxAssetsLiabilities	39932000	USD
CY2018Q4	axgn	Deferred Tax Assets Liabilities DeferredTaxAssetsLiabilities	33876000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	46517000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	39932000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	33876000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.073
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.041
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	-0.006
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	-0.043
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.277
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.208
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6585000	USD
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6056000	USD
CY2018	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	5519000	USD
CY2020Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	42317000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020Q3	us-gaap	Tenant Improvements TenantImprovements	11539000	USD
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	22000	USD
CY2019	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	22000	USD
CY2020	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	3000	USD
CY2019	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	4000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	2777000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	1910000	USD
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	116000	USD
CY2019	us-gaap	Short Term Lease Cost ShortTermLeaseCost	41000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	18000	USD
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	17000	USD
CY2020	us-gaap	Lease Cost LeaseCost	2936000	USD
CY2019	us-gaap	Lease Cost LeaseCost	1994000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15614000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3133000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	846000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1719000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	20864000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1565000	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	64000	USD
CY2019Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	87000	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	17000	USD
CY2019Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	17000	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	13000	USD
CY2019Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	30000	USD
CY2020	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	1913000	USD
CY2019	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	1773000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	16000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	16000	USD
CY2020Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2019Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2020Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0728
CY2019Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0728
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0944
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0628
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3030000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	19000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3750000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	10000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2545000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	3000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2606000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2671000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	0	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	26677000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	41279000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	32000	USD
CY2020Q4	axgn	Lessee Operating Lease Liability Future Payments Amount LesseeOperatingLeaseLiabilityFuturePaymentsAmount	0	USD
CY2020Q4	axgn	Finance Lease Liability Future Payments Amount FinanceLeaseLiabilityFuturePaymentsAmount	0	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	19573000	USD
CY2020Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	2000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	21706000	USD
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	30000	USD
CY2019Q1	axgn	Threshold Period For Not Filing Response To Complaint ThresholdPeriodForNotFilingResponseToComplaint	P30D
CY2020Q1	us-gaap	Revenues Revenues	24261000	USD
CY2020Q2	us-gaap	Revenues Revenues	22116000	USD
CY2020Q3	us-gaap	Revenues Revenues	33428000	USD
CY2020Q4	us-gaap	Revenues Revenues	32495000	USD
CY2020	us-gaap	Revenues Revenues	112300000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	19445000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	16511000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	27731000	USD
CY2020Q4	us-gaap	Gross Profit GrossProfit	27032000	USD
CY2020	us-gaap	Gross Profit GrossProfit	90719000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-8192000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-8105000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-1479000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-6010000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23786000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2020Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.15
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.60
CY2019Q1	us-gaap	Revenues Revenues	23285000	USD
CY2019Q2	us-gaap	Revenues Revenues	26701000	USD
CY2019Q3	us-gaap	Revenues Revenues	28564000	USD
CY2019Q4	us-gaap	Revenues Revenues	28162000	USD
CY2019	us-gaap	Revenues Revenues	106712000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	19571000	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	22457000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	24054000	USD
CY2019Q4	us-gaap	Gross Profit GrossProfit	23281000	USD
CY2019	us-gaap	Gross Profit GrossProfit	89363000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-9504000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-7022000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-5571000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-7038000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-29135000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.24
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.18
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
CY2019Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.18
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.74

Files In Submission

Name	View Source	Status
0000805928-21-000044-index-headers.html	Edgar Link	pending
0000805928-21-000044-index.html	Edgar Link	pending
0000805928-21-000044.txt	Edgar Link	pending
0000805928-21-000044-xbrl.zip	Edgar Link	pending
a2020consent.htm	Edgar Link	pending
axgn-20201231.htm	Edgar Link	pending
axgn-20201231.xsd	Edgar Link	pending
axgn-20201231xex311.htm	Edgar Link	pending
axgn-20201231xex312.htm	Edgar Link	pending
axgn-20201231xex321.htm	Edgar Link	pending
axgn-20201231_cal.xml	Edgar Link	unprocessable
axgn-20201231_def.xml	Edgar Link	unprocessable
axgn-20201231_g1.jpg	Edgar Link	pending
axgn-20201231_g2.jpg	Edgar Link	pending
axgn-20201231_htm.xml	Edgar Link	completed
axgn-20201231_lab.xml	Edgar Link	unprocessable
axgn-20201231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
subsidiariesoftheregistran.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AXGN
Axogen, Inc. Stock $axgn

2020 Q4 Form 10-K Financial Statement

#000080592821000044 Filed on March 01, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AXGN Axogen, Inc. Stock $axgn

2020 Q4 Form 10-K Financial Statement

#000080592821000044 Filed on March 01, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AXGN
Axogen, Inc. Stock $axgn